Free Trial

Kalaris Therapeutics (KLRS) SEC Filings & 10K Form

Kalaris Therapeutics logo
$3.56 +0.48 (+15.58%)
As of 04:00 PM Eastern

Recent Kalaris Therapeutics SEC Filings

DateFilerForm TypeView
08/13/2025
7:11 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2025
7:16 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025
6:40 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form ARS
07/01/2025
6:30 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form DEF 14A
07/01/2025
6:35 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form DEFA14A
06/20/2025
6:20 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
1:06 PM
EcoR1 Capital, LLC (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
7:09 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
3:18 PM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2025
4:04 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:08 PM
Jovan-Embiricos Morana (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:20 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:27 PM
Hagen Brett R (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
4:03 PM
Ferrara Napoleone (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
3:41 PM
Hallal David (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
7:21 AM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATTERSON LEONE D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2025
7:12 AM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
6:19 PM
Hagen Brett R (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3/A
03/25/2025
6:38 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2025
6:40 PM
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13D
03/20/2025
3:32 PM
GILEAD SCIENCES, INC. (Filed by)
Kalaris Therapeutics, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form SCHEDULE 13G/A
03/18/2025
4:44 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:45 PM
Ferrara Napoleone (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:37 PM
ADAMIS ANTHONY P (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:40 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:41 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:43 PM
Feinsod Matthew (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:25 PM
Dybbs Michael (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:27 PM
Ferrara Napoleone (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:30 PM
AKKARAJU SRINIVAS (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:14 PM
ADAMIS ANTHONY P (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:17 PM
Feinsod Matthew (Reporting)
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:20 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Oxtoby Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:21 PM
Kalaris Therapeutics, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:04 PM
Kalaris Therapeutics, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:18 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:30 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
10:51 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:55 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:56 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Altucher: It Looks Like My Trump prediction is coming true (Ad)

New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.tc pixel

See Altucher’s Trump crypto prediction here
02/14/2025
12:17 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
11:15 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form EFFECT
02/10/2025
3:19 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 424B3
01/24/2025
1:51 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
1:55 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
2:03 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:39 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:41 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
01/13/2025
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
6:44 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
01/10/2025
6:42 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:21 PM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:23 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
12/11/2024
4:07 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:37 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/06/2024
8:50 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
12/06/2024
6:23 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form DEF 14A
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
3:06 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
3:09 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
3:10 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/08/2024
7:26 AM
Allovir, Inc. (Filer)
Kalaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Form 425
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A New Way to Double Your Retirement Income? (Ad)

Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel

Click here to see how to turn your savings into a monthly income machine.
10/21/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
Allovir, Inc. (Issuer)
Kalaris Therapeutics (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
Allovir, Inc. (Subject)
Kalaris Therapeutics (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KLRS) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners